PRNP and prion disease: Furthermore, αS-immunoreactive deposits were identified in the central nervous system of various prion diseases, including sporadic, iatrogenic and new variant CJD, while the immunoreactivity of PrP and those of APs were not strictly co-localized particularly in the plaques, in experimental scrapie of hamsters [8] (Figure 1(b)).